The updated guidance by NICE revealed that hormone replacement therapy (HRT) neither shortens nor lengthens life expectancy, dispelling common concerns about its long-term effects.
Dr. Marie Anne Ledingham emphasized that the independent panel found no increased risk for coronary heart disease or stroke among women using combined HRT compared to non-users.
The guidance offers a detailed framework for GPs to engage with patients, including a new discussion aid designed to facilitate informed decision-making regarding HRT treatment.
While HRT carries a slight increase in breast cancer risk, it also significantly lowers the risk of osteoporosis fractures in postmenopausal women.
Collection
[
|
...
]